Kane RL - Search Results

1

Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women.

Schousboe JT, Nyman JA, Kane RL, Ensrud KE. Schousboe JT, et al. Among authors: kane rl. Ann Intern Med. 2005 May 3;142(9):734-41. doi: 10.7326/0003-4819-142-9-200505030-00008. Ann Intern Med. 2005. PMID: 15867405

2

Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy.

Schousboe JT, Ensrud KE, Nyman JA, Kane RL, Melton LJ 3rd. Schousboe JT, et al. Among authors: kane rl. Osteoporos Int. 2005 Dec;16(12):1883-93. doi: 10.1007/s00198-005-1956-7. Epub 2005 Aug 31. Osteoporos Int. 2005. PMID: 16133649

3

Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.

Schousboe JT, Ensrud KE, Nyman JA, Melton LJ 3rd, Kane RL. Schousboe JT, et al. Among authors: kane rl. J Am Geriatr Soc. 2005 Oct;53(10):1697-704. doi: 10.1111/j.1532-5415.2005.53504.x. J Am Geriatr Soc. 2005. PMID: 16181168

4

Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-score>-2.5 for alendronate therapy: a modeling study.

Schousboe JT, Ensrud KE, Nyman JA, Kane RL, Melton LJ 3rd. Schousboe JT, et al. Among authors: kane rl. J Clin Densitom. 2006 Apr-Jun;9(2):133-43. doi: 10.1016/j.jocd.2005.11.004. Epub 2006 Apr 18. J Clin Densitom. 2006. PMID: 16785071

5

Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.

Schousboe JT, Taylor BC, Fink HA, Kane RL, Cummings SR, Orwoll ES, Melton LJ 3rd, Bauer DC, Ensrud KE. Schousboe JT, et al. Among authors: kane rl. JAMA. 2007 Aug 8;298(6):629-37. doi: 10.1001/jama.298.6.629. JAMA. 2007. PMID: 17684185

6

Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy.

Schousboe JT, Bauer DC, Nyman JA, Kane RL, Melton LJ, Ensrud KE. Schousboe JT, et al. Among authors: kane rl. Osteoporos Int. 2007 Feb;18(2):201-10. doi: 10.1007/s00198-006-0218-7. Epub 2006 Sep 20. Osteoporos Int. 2007. PMID: 17019515

7

Predictors of patients' perceived need for medication to prevent fracture.

Schousboe JT, Davison ML, Dowd B, Thiede Call K, Johnson P, Kane RL. Schousboe JT, et al. Among authors: kane rl. Med Care. 2011 Mar;49(3):273-80. doi: 10.1097/MLR.0b013e318202915e. Med Care. 2011. PMID: 21224740

8

Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis.

Michaud TL, Kane RL, McCarten JR, Gaugler JE, Nyman JA, Kuntz KM. Michaud TL, et al. Among authors: kane rl. Pharmacoecon Open. 2018 Sep;2(3):309-323. doi: 10.1007/s41669-017-0054-z. Pharmacoecon Open. 2018. PMID: 29623628 Free PMC article.

9

Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures.

Schousboe JT, Dowd BE, Davison ML, Kane RL. Schousboe JT, et al. Among authors: kane rl. Osteoporos Int. 2010 Nov;21(11):1899-909. doi: 10.1007/s00198-009-1141-5. Epub 2009 Dec 5. Osteoporos Int. 2010. PMID: 19967337

10

Treatments for Fibromyalgia in Adult Subgroups [Internet].

Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL. Forte ML, et al. Among authors: kane rl. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Jan. Report No.: 15-EHC006-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Jan. Report No.: 15-EHC006-EF. PMID: 25719189 Free Books & Documents. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

594 results

Search Page

Filters